Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02146833 |
Title | Study of Selinexor (KPT-330) in Metastatic Castrate Resistant Prostate Adenocarcinoma |
Acronym | SHIP |
Recruitment | Terminated |
Gender | male |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Karyopharm Therapeutics, Inc |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
M.D. Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |